Literature DB >> 15991293

Role of cytokines in promoting immune escape of FasL-expressing human colon cancer cells.

Tong Xu1, Bao-Cun Sun, Qiang Li, Xi-Shan Hao.   

Abstract

AIM: To investigate the potential role of cytokines in promoting Fas ligand (FasL)-expressing colon cancer cells.
METHODS: Immunohistochemical SABC method was used to observe the expression of Fas receptor and ligand in SW620 colon cancer cell line and Jurkat T cells in order to provide the morphological evidence for the functions of Fas receptor and ligand. To examine the cytotoxicity of effector cells, CytoTox96(r) non-radioactive cytotoxicity assay was adopted to measure the lactate dehydrogenase-releasing value after SW620 cells were co-cultured with Jurkat T lymphocytes.
RESULTS: The FasL of colon cancer SW620 cells was positive. The positive substances were distributed in the cell membrane and cytoplasm. The Fas receptor of colon cancer SW620 cells was negative. The Fas receptor and ligand of Jurkat T lymphocytes turned out to be positive. The positive substances were distributed in the cell membrane. After phytohemagglutinin (PHA)-stimulated Jurkat T lymp-hocytes were co-cultured with phorbol 12-myristate 13-acetate (PMA)-plus-ionomycin-stimulated (for 48 h) SW620 cells or tumor necrosis factor-alpha (TNF-alpha)-stimulated (for 48 h) SW620 cells or unstimulated SW620 cells for 4 h, the cytotoxicity of SW620 cells to PHA-stimulated Jurkat cells at effector-to-target ratios of 10:1, 5:1, 2.5:1, and 1.25:1 was 74.6%, 40.8%, 32.4%, and 10.9% (F = 8.19, P<0.05); or 54.9%, 35.3%, 22.0%, and 10.3% (F = 11.12, P<0.05); or 14.9%, 10.5%, 6.9%, and 5.8% (F = 3.45, P<0.05). After PHA-stimulated Jurkat T lymphocytes were co-cultured with unstimulated SW620 cells for 8 h, the cytotoxicity of SW620 cells to PHA-stimulated Jurkat cells at effector-to-target ratios of 5:1, 2.5:1, and 1.25:1 from the experiment was 83.9%, 74.1%, and 28.5% (F = 137.04, P<0.05) respectively. Non-radioactive cytotoxicity assay showed that the apoptotic rate of Jurkat cells remarkably increased with the increase of planting concentration of SW620 cells and co-culture time after the SW620 cells were co-cultured with the Jurkat T lymphocytes. The cytotoxicity was significantly enhanced by PMA+ionomycin or TNF-alpha.
CONCLUSION: The FasL expressed in human colon cancer cells may be regulated by endogenous factors in the microenvironment of the host and facilitate the escape of tumor cells from the host immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15991293      PMCID: PMC4504896          DOI: 10.3748/wjg.v11.i25.3915

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  21 in total

Review 1.  Defective death receptor signaling as a cause of tumor immune escape.

Authors:  Lars E French; Jürg Tschopp
Journal:  Semin Cancer Biol       Date:  2002-02       Impact factor: 15.707

Review 2.  Fas (CD95, Apo-1) ligand gene transfer.

Authors:  S E Lamhamedi-Cherradi; Y Chen
Journal:  J Clin Immunol       Date:  2001-01       Impact factor: 8.317

3.  Anti-Fas on nonhematopoietic tumors: levels of Fas/APO-1 and bcl-2 are not predictive of biological responsiveness.

Authors:  L B Owen-Schaub; R Radinsky; E Kruzel; K Berry; S Yonehara
Journal:  Cancer Res       Date:  1994-03-15       Impact factor: 12.701

4.  Fas-mediated suicide of tumor-reactive T cells following activation by specific tumor: selective rescue by caspase inhibition.

Authors:  T Z Zaks; D B Chappell; S A Rosenberg; N P Restifo
Journal:  J Immunol       Date:  1999-03-15       Impact factor: 5.422

5.  Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis.

Authors:  P T Daniel; A Kroidl; S Cayeux; R Bargou; T Blankenstein; B Dörken
Journal:  J Immunol       Date:  1997-10-15       Impact factor: 5.422

Review 6.  The Fas signalling pathway and its role in the pathogenesis of cancer.

Authors:  Aileen Houston; Joe O'Connell
Journal:  Curr Opin Pharmacol       Date:  2004-08       Impact factor: 5.547

7.  [The role of Fas/Fas ligand in tumorgenesis, immune escape, and counterattack in colonic cancer].

Authors:  Qiang Zhu; Changsheng Deng
Journal:  Zhonghua Nei Ke Za Zhi       Date:  2002-06

8.  In vitro cell-mediated cytotoxicity against allogeneic erythrocytes in ginbuna crucian carp and goldfish using a non-radioactive assay.

Authors:  U Fischer; M Ototake; T Nakanishi
Journal:  Dev Comp Immunol       Date:  1998 Mar-Apr       Impact factor: 3.636

9.  IFN-gamma induces cell growth inhibition by Fas-mediated apoptosis: requirement of STAT1 protein for up-regulation of Fas and FasL expression.

Authors:  X Xu; X Y Fu; J Plate; A S Chong
Journal:  Cancer Res       Date:  1998-07-01       Impact factor: 12.701

10.  Fas ligand mediates immune privilege and not inflammation in human colon cancer, irrespective of TGF-beta expression.

Authors:  A Houston; M W Bennett; G C O'Sullivan; F Shanahan; J O'Connell
Journal:  Br J Cancer       Date:  2003-10-06       Impact factor: 7.640

View more
  1 in total

Review 1.  Horizontal gene transfers with or without cell fusions in all categories of the living matter.

Authors:  Joseph G Sinkovics
Journal:  Adv Exp Med Biol       Date:  2011       Impact factor: 2.622

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.